
A recent HS Summit hosted by UCB brought together clinicians and patient advocates to strengthen research and awareness efforts.
Chaquira Andrade is a patient advocate for hidradenitis suppurativa. She was involved in the clinical trial leading to the 2024 approval of bimekizumab for HS, and speaks about her journey both online and at dermatologic meetings.

A recent HS Summit hosted by UCB brought together clinicians and patient advocates to strengthen research and awareness efforts.

Andrade's inspiring journey highlights the challenges of HS and the transformative impact of clinical trials.

Published: August 15th 2025 | Updated: